Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Type 2 diabetes history is positively associated w/ risk of diffuse large B-cell lymphoma (HR: 1.15) and myeloma (1.20) but inversely associated with risk of lymphoplasmacytic lymphoma/#Waldenström macroglobulinemia (0.45)”
Title: Type 2 diabetes and risk of non-Hodgkin lymphoma and multiple myeloma: a pooled analysis
Authors: Andres Ardisson Korat, Emily Deubler, Kimberly Bertrand, Lauren Teras, James Lacey, Alpa Patel, Bernard Rosner, Yu-Hsiang Shu, Charlie Zhong, Sophia Wang, Brenda Birmann, Chun Chao
You can read the Full Article in JNCI Cancer Spectrum.
You can find other articles featuring Robert Orlowski on OncoDaily.
